Reynir Arngrı́msson

Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document

Marieke Biegstraaten, Reynir Arngrı́msson, Frédéric Barbey et al. · Orphanet Journal of Rare Diseases · 2015 · 345 citations · Full text

Life Sciences, Internal Medicine, Pharmacotherapy +13

Genetic and familial predisposition to eclampsia and pre‐eclampsia in a defined population

Reynir Arngrı́msson, S Bjornsson, Reynir Tómas Geirsson et al. · BJOG An International Journal of Obstetrics & Gynaecology · 1990 · 300 citations

Life Sciences, Obstetrics, Genetic Epidemiology +7

Death rates from ischemic heart disease in women with a history of hypertension in pregnancy

Lilja Sjónsdóttir, Reynir Arngrı́msson, Reynir Tómas Geirsson et al. · Acta Obstetricia Et Gynecologica Scandinavica · 1995 · 286 citations

Medicine, Cardiology, Obstetrics +11

Epidemiology of Dupuytren's disease

Kristján G. Guðmundsson, Reynir Arngrı́msson, Nikulás Sigfússon et al. · Journal of Clinical Epidemiology · 2000 · 215 citations

Public Health, Endocrinology, Epidemiology +2

A genome-wide scan for preeclampsia in the Netherlands

Augusta MA Lachmeijer, Reynir Arngrı́msson, Esther J. Bastiaans et al. · European Journal of Human Genetics · 2001 · 200 citations · Full text

Public Health, Genetics, Obstetrics +12